Skip to main content
. 2020 May 25;12:3859–3864. doi: 10.2147/CMAR.S254093

Table 3.

Variation of Diagnosis and Treatment Path of NPC Under the Controlling Measure of the COVID-19

Variation of Events Group A
n (%)
Group B
n (%)
P value
Additional chemotherapy received 2 (5.9) 11 (32.4) 0.006
Concurrent chemotherapy reduced 8 (15.4) 6 (25.0) 0.315

Abbreviation: NPC, nasopharyngeal carcinoma.